Skip to content
healthcare.dev

Abiraterone Acetate

NDC 50268-032, Abiraterone Acetate, tablet, from AvPAK.

Product NDC
50268-032
Status
Listed
Labeler
AvPAK
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208416
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50268-032 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABIRATERONE ACETATE250 mg/1

Pharmacologic classes

Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Package NDCNDC-11Package
50268-032-125026800321220 BLISTER PACK in 1 BOX (50268-032-12) / 1 TABLET in 1 BLISTER PACK (50268-032-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5108c2fe-9706-c976-e063-6294a90a796d
  • NADAC price for package 50268003212

    GET /v1/drugs/nadac/50268003212

Use it

Look up 50268-032 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50268-032 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50268-032. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.